skip to content
Log in Sign up
Cart (0)
PEFRAKEHL, fluconazole, vaginal yeast infection women UK
Sale

PEFRAKEHL, fluconazole, vaginal yeast infection women

SANUM-KEHLBECK GmbH & Co. KG

£59.90 £90.00

Tax included. Shipping calculated at checkout.

PEFRAKEHL capsules D 4 20 pcs, fluconazole, vaginal yeast infection women

Pefrakehl D4 hard capsules, fluconazole, vaginal yeast infection women



Registered homeopathic medicinal product, therefore no indication of a therapeutic indication. Application: The following applies to adults and adolescents from the age of 12: Take 1-3 hard capsules daily before breakfast or in the evening before going to bed with sufficient liquid. Pefrakehl D4 should be discontinued after a maximum of 4 weeks of therapy.

Note:
Contains lactose.

Homeopathic medicine.

active PEFRAKEHL, fluconazole, vaginal yeast infection women ingredients

  • 330 mg Candida parapsilosis e volumine mycelii (lyophil., sterile.) D4

PEFRAKEHL, fluconazole, vaginal yeast infection women excipients

  • lactose
  • hypromellose


C. parapsilosis vaginal yeast infections are treated with a course of antifungal medication that may be taken in various forms, including oral pills, suppository capsules, or topical treatments. Examples include: fluconazole.

Preparation group:
fungal preparation

Active ingredient:
Candida parapsilosis e volumine mycelii (lyophil., sterile.) Trit. D4

Composition:
1 hard capsule contains: 330 mg Candida parapsilosis e volumine mycelii (lyophil., sterile.) Trit. D4 (HAB, rule 6).

Excipients
: Hard capsule shell: hypromellose (HPMC).

Experience has shown that it is used for:
Registered homeopathic medicinal product, therefore without indication of a therapeutic indication.

Application:
Unless otherwise prescribed, the following applies to adults and adolescents from the age of 12: Take 1-3 hard capsules daily before breakfast or in the evening before going to bed with sufficient liquid. Pefrakehl® D4 should be discontinued after a maximum of 4 weeks of therapy.

Side effects:
Due to the content of specific organic components in Pefrakehl® D4, hypersensitivity reactions, mainly in the form of skin reactions, can occur and an allergy to the component Candida parapsilosis can be triggered. The drug should then be discontinued and a doctor consulted.

Contraindications:
Do not use with:

  • Known hypersensitivity to yeast (Candida parapsilosis)
  • autoimmune diseases
  • children under 12 years of age
  • pregnant and lactating women

Interactions:
Drugs with an immunosuppressive effect can impair the effectiveness of Pefrakehl® D4. An interval of 4 weeks should be observed before and after treatment with orally administered live vaccines.

Precautions:
This medicine contains lactose. Therefore, please only take Pefrakehl® D4 after consulting your doctor if you know that you suffer from an intolerance to certain sugars.

Note:
Contains lactose.

Additional PEFRAKEHL, fluconazole, vaginal yeast infection women note :


Candida parapsilosis is also contained as an active ingredient in the combination preparation Exmykehl®.